Cell cycle-driven heterogeneity: On the road to demystifying the transitions between "poised" and "restricted" pluripotent cell states

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Singh, Amar M ^a  

^a University of Georgia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; RNA; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; WNT3 PROTEIN;

ARTICLE; CANCER STEM CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FATE; CELL HETEROGENEITY; CELLS BY BODY ANATOMY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN STABILITY; RNA SEQUENCE; RNA TRANSLATION; STEM CELL CULTURE;

EID: 84928542245     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/219514     Document Type: Article

References (92)

1. A. G. Smith, "Embryo-derived stem cells: of mice and men, " Annual Review of Cell and Developmental Biology, vol. 17, pp. 435-462, 2001.
2. A. K. K. Teo, S. J. Arnold, M. W. B. Trotter et al., "Pluripotency factors regulate definitive endoderm specification through eomesodermin, " Genes and Development, vol. 25, no. 3, pp. 238-250, 2011.
3. M. Thomson, S. J. Liu, L.-N. Zou, Z. Smith, A. Meissner, and S. Ramanathan, "Pluripotency factors in embryonic stem cells regulate differentiation into germlayers, " Cell, vol. 145, no. 6, pp. 875-889, 2011.
4. G. C. Le Bin, S. Muñoz-Descalzo, A. Kurowski et al., "Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst, " Development, vol. 141, no. 5, pp. 1001-1010, 2014.
5. J. Shu, C. Wu, Y. Wu et al., "XInduction of pluripotency in mouse somatic cells with lineage specifiers, " Cell, vol. 153, no. 5, pp. 963-975, 2013.
6. N. Montserrat, E. Nivet, I. Sancho-Martinez et al., "Reprogramming of human fibroblasts to pluripotency with lineage specifiers, " Cell Stem Cell, vol. 13, no. 3, pp. 341-350, 2013.
7. P. D. Tonge, A. J. Corso, C. Monetti et al., "Divergent reprogramming routes lead to alternative stem-cell states, " Nature, vol. 516, no. 7530, pp. 192-197, 2014.
8. S. M. I. Hussein, M. C. Puri, P. D. Tonge et al., "Genome-wide characterization of the routes to pluripotency, " Nature, vol. 516, no. 7530, pp. 198-206, 2014.
9. T. Graf and M. Stadtfeld, "Heterogeneity of embryonic and adult stem cells, " Cell Stem Cell, vol. 3, no. 5, pp. 480-483, 2008.
10. P. Cahan and G. Q. Daley, "Origins and implications of pluripotent stem cell variability and heterogeneity, " Nature Reviews Molecular Cell Biology, vol. 14, no. 6, pp. 357-368, 2013.
11. A. Martinez Arias and J. M. Brickman, "Gene expression heterogeneities in embryonic stem cell populations: origin and function, " Current Opinion in Cell Biology, vol. 23, no. 6, pp. 650-656, 2011.
12. A. M. Singh, J. Chappell, R. Trost et al., "Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells, " Stem Cell Reports, vol. 1, no. 6, pp. 532-544, 2013.
13. S. Pauklin and L. Vallier, "The cell-cycle state of stem cells determines cell fate propensity, " Cell, vol. 155, no. 1, pp. 135-147, 2013.
14. Q.-L. Ying, J. Wray, J. Nichols et al., "The ground state of embryonic stem cell self-renewal, " Nature, vol. 453, no. 7194, pp. 519-523, 2008.
15. P. J. Tesar, J. G. Chenoweth, F. A. Brook et al., "New cell lines from mouse epiblast share defining features with human embryonic stem cells, " Nature, vol. 448, no. 7150, pp. 196-199, 2007.
16. I. G. M. Brons, L. E. Smithers, M. W. B. Trotter et al., "Derivation of pluripotent epiblast stem cells from mammalian embryos, " Nature, vol. 448, no. 7150, pp. 191-195, 2007.
17. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., "Embryonic stem cell lines derived from human blastocysts, " Science, vol. 282, no. 5391, pp. 1145-1147, 1998.
18. S. R. Hough, A. L. Laslett, S. B. Grimmond, G. Kolle, and M. F. Pera, "A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells, " PLoS ONE, vol. 4, no. 11, Article ID e7708, 2009.
19. A. M. Singh and S. Dalton, "The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming, " Cell Stem Cell, vol. 5, no. 2, pp. 141-149, 2009.
20. K. Kapinas, R. Grandy, P. Ghule et al., "The abbreviated pluripotent cell cycle, " Journal of Cellular Physiology, vol. 228, no. 1, pp. 9-20, 2013.
21. I. Neganova and M. Lako, "G1 to S phase cell cycle transition in somatic and embryonic stem cells, " Journal of Anatomy, vol. 213, no. 1, pp. 30-44, 2008.
22. J. White and S. Dalton, "Cell cycle control of embryonic stem cells, " Stem Cell Reviews, vol. 1, no. 2, pp. 131-138, 2005.
23. E. Stead, J. White, R. Faast et al., "Pluripotent cell division cycles aredrivenby ectopicCdk2, cyclinA/EandE2Factivities, " Oncogene, vol. 21, no. 54, pp. 8320-8333, 2002.
24. P. Savatier, H. Lapillonne, L. A. van Grunsven, B. B. Rudkin, and J. Samarut, "Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells, " Oncogene, vol. 12, no. 2, pp. 309-322, 1996.
25. T. Kunath, M. K. Saba-El-Leil, M. Almousailleakh, J. Wray, S. Meloche, and A. Smith, "FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment, " Development, vol. 134, no. 16, pp. 2895-2902, 2007.
26. A. M. Singh, D. Reynolds, T. Cliff et al., "Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation, " Cell Stem Cell, vol. 10, no. 3, pp. 312-326, 2012.
27. S. Dalton, "Signaling networks in human pluripotent stemcells, " Current Opinion in Cell Biology, vol. 25, no. 2, pp. 241-246, 2013.
28. H. Sun, R. Lesche, D. M. Li et al., "PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 6199-6204, 1999.
29. K. A. Becker, P. N. Ghule, J. A. Therrien et al., "Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase, " Journal of Cellular Physiology, vol. 209, no. 3, pp. 883-893, 2006.
30. P. N. Ghule, K. A. Becker, J. W. Harper et al., "Cell cycle dependent phosphorylation and subnuclear organization of the histone gene regulator p220 in human embryonic stem cells, " Journal of Cellular Physiology, vol. 213, no. 1, pp. 9-17, 2007.
31. I. Neganova, X. Zhang, S. Atkinson, and M. Lako, "Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells, " Oncogene, vol. 28, no. 1, pp. 20-30, 2009.
32. C. L. Mummery, M. A. van Rooijen, S. E. van den Brink, and S. W. de Laat, "Cell cycle analysis during retinoic acid induced differentiation of a human embryonal carcinoma-derived cell line, " Cell Differentiation, vol. 20, no. 2, pp. 153-160, 1987.
33. Y. Sela, N. Molotski, S. Golan, J. Itskovitz-Eldor, and Y. Soen, "Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein, " StemCells, vol. 30, no. 6, pp. 1097-1108, 2012.
34. S. Chetty, F. W. Pagliuca, C. Honore, A. Kweudjeu, A. Rezania, and D. A. Melton, "A simple tool to improve pluripotent stem cell differentiation, " Nature Methods, vol. 10, no. 6, pp. 553-556, 2013.
35. A. Sakaue-Sawano, H. Kurokawa, T. Morimura et al., "Visualizing spatiotemporal dynamics of multicellular cell-cycle progression, " Cell, vol. 132, no. 3, pp. 487-498, 2008.
36. A. Calder, I. Roth-Albin, S. Bhatia et al., "Lengthened G1 phase indicates differentiation status in human embryonic stem cells, " Stem Cells and Development, vol. 22, no. 2, pp. 279-295, 2013.
37. D. Coronado, M. Godet, P.-Y. Bourillot et al., "A short G1 phase is an intrinsic determinant of naïve embryonic stem cell pluripotency, " StemCell Research, vol. 10, no. 1, pp. 118-131, 2013.
38. M. Roccio, D. Schmitter, M. Knobloch, Y. Okawa, D. Sage, and M. P. Lutolf, "Predicting stem cell fate changes by differential cell cycle progression patterns, " Development, vol. 140, no. 2, pp. 459-470, 2013.
39. S. Dalton, "G1 compartmentalization and cell fate coordination, " Cell, vol. 155, no. 1, pp. 13-14, 2013.
40. Y. Nakai-Futatsugi and H. Niwa, "Transcription factor network in embryonic stem cells: heterogeneity under the stringency, " Biological and Pharmaceutical Bulletin, vol. 36, no. 2, pp. 166-170, 2013.
41. M.-E. Torres-Padilla and I. Chambers, "Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage, " Development, vol. 141, no. 11, pp. 2173-2181, 2014.
42. B. D. Macarthur and I. R. Lemischka, "Statistical mechanics of pluripotency, " Cell, vol. 154, no. 3, pp. 484-489, 2013.
43. T. Enver, M. Pera, C. Peterson, and P. W. Andrews, "Stem cell states, fates, and the rules of attraction, " Cell Stem Cell, vol. 4, no. 5, pp. 387-397, 2009.
44. K. Hayashi, S. M. C. D. S. Lopes, F. Tang, and M. A. Surani, "Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states, " Cell Stem Cell, vol. 3, no. 4, pp. 391-401, 2008.
45. S.-Y. Hatano, M. Tada, H. Kimura et al., "Pluripotential competence of cells associated with Nanog activity, " Mechanisms of Development, vol. 122, no. 1, pp. 67-79, 2005.
46. I. Chambers, J. Silva, D. Colby et al., "Nanog safeguards pluripotency andmediates germline development, " Nature, vol. 450, no. 7173, pp. 1230-1234, 2007.
47. A. M. Singh, T. Hamazaki, K. E. Hankowski, and N. Terada, "A heterogeneous expression pattern forNanog in embryonic stem cells, " Stem Cells, vol. 25, no. 10, pp. 2534-2542, 2007.
48. Y. Toyooka, D. Shimosato, K. Murakami, K. Takahashi, and H. Niwa, "Identification and characterization of subpopulations in undifferentiated ES cell culture, " Development, vol. 135, no. 5, pp. 909-918, 2008.
49. D. W. Han, N. Tapia, J. Y. Joo et al., "Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages, " Cell, vol. 143, no. 4, pp. 617-627, 2010.
50. N. Festuccia, R. Osorno, F. Halbritter et al., "Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells, " Cell Stem Cell, vol. 11, no. 4, pp. 477-490, 2012.
51. R. M. Kumar, P. Cahan, A. K. Shalek et al., "Deconstructing transcriptional heterogeneity in pluripotent stem cells, " Nature, vol. 516, no. 7529, pp. 56-61, 2014.
52. H. Niwa, K. Ogawa, D. Shimosato, and K. Adachi, "A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells, " Nature, vol. 460, no. 7251, pp. 118-122, 2009.
53. M. Zalzman, G. Falco, L. V. Sharova et al., "Zscan4 regulates telomere elongation and genomic stability in ES cells, " Nature, vol. 464, no. 7290, pp. 858-863, 2010.
54. T. Kalmar, C. Lim, P. Hayward et al., "Regulated fluctuations in Nanog expressionmediate cell fate decisions in embryonic stem cells, " PLoS Biology, vol. 7, no. 7, Article ID e1000149, 2009.
55. B. D. Macarthur, A. Sevilla, M. Lenz et al., "Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity, " Nature Cell Biology, vol. 14, no. 11, pp. 1139-1147, 2012.
56. Y. Miyanari and M.-E. Torres-Padilla, "Control of ground-state pluripotency by allelic regulation of Nanog, " Nature, vol. 483, no. 7390, pp. 470-473, 2012.
57. D. A. Faddah, H. Wang, A. W. Cheng, Y. Katz, Y. Buganim, and R. Jaenisch, "Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs, " Cell Stem Cell, vol. 13, no. 1, pp. 23-29, 2013.
58. A. Filipczyk, K. Gkatzis, J. Fu et al., "Biallelic expression of nanog protein in mouse embryonic stem cells, " Cell Stem Cell, vol. 13, no. 1, pp. 12-13, 2013.
59. P. Navarro, N. Festuccia, D. Colby et al., "OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells, " The EMBO Journal, vol. 31, no. 24, pp. 4547-4562, 2012.
60. H. Ochiai, T. Sugawara, T. Sakuma, and T. Yamamoto, "Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells, " Scientific Reports, vol. 4, article 7125, 2014.
61. E. Abranches, A. M. Guedes, M. Moravec et al., "Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency, " Development, vol. 141, no. 14, pp. 2770-2779, 2014.
62. S. van der Laan, E. Golfetto, J.-M. Vanacker, and D. Maiorano, "Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells, " PLoS ONE, vol. 9, no. 4, Article ID e93663, 2014.
63. X. Zhang, I. Neganova, S. Przyborski et al., "A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A, " Journal of Cell Biology, vol. 184, no. 1, pp. 67-82, 2009.
64. D. A. G. Card, P. B. Hebbar, L. Li et al., "Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cell, " Molecular and Cellular Biology, vol. 28, no. 20, pp. 6426-6438, 2008.
65. K. B. Scotland, S. Chen, R. Sylvester, and L. J. Gudas, "Analysisof Rex1 (Zfp42) function in embryonic stem cell differentiation, " Developmental Dynamics, vol. 238, no. 8, pp. 1863-1877, 2009.
66. H. S. Yoon and V. W. Yang, "Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage, " The Journal of Biological Chemistry, vol. 279, no. 6, pp. 5035-5041, 2004.
67. M. H. Stewart, M. Bossé, K. Chadwick, P. Menendez, S. C. Bendall, and M. Bhatia, "Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment, " Nature Methods, vol. 3, no. 10, pp. 807-815, 2006.
68. K. K. Niakan, H. Ji, R. Maehr et al., "Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal, " Genes and Development, vol. 24, no. 3, pp. 312-326, 2010.
69. M. A. Canham, A. A. Sharov, M. S. H. Ko, and J. M. Brickman, "Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript, " PLoS Biology, vol. 8, no. 5, 2010.
70. T. Kobayashi, H. Mizuno, I. Imayoshi, C. Furusawa, K. Shirahige, and R. Kageyama, "The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cells, " Genes and Development, vol. 23, no. 16, pp. 1870-1875, 2009.
71. S. Hough, M. Thornton, E. Mason, J. Mar, C. Wells, and M. Pera, "Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells, " Stem Cell Reports, vol. 2, no. 6, pp. 881-895, 2014.
72. H. Marks, T. Kalkan, R. Menafra et al., "The transcriptional and epigenomic foundations of ground state pluripotency, " Cell, vol. 149, no. 3, pp. 590-604, 2012.
73. F. Yi, L. Pereira, J. A. Hoffman et al., "Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell selfrenewal, " Nature Cell Biology, vol. 13, no. 7, pp. 762-770, 2011.
74. J. Wray, T. Kalkan, S. Gomez-Lopez et al., "Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation, " Nature Cell Biology, vol. 13, no. 7, pp. 838-845, 2011.
75. N. Lyashenko, M. Winter, D. Migliorini, T. Biechele, R. T. Moon, and C. Hartmann, "Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germlayer formation, " Nature Cell Biology, vol. 13, no. 7, pp. 753-761, 2011.
76. D. T. Berge, D. Kurek, T. Blauwkamp et al., "Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells, " Nature Cell Biology, vol. 13, no. 9, pp. 1070-1077, 2011.
77. Y. Chen, K. Blair, and A. Smith, "Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition, " Stem Cell Reports, vol. 1, no. 3, pp. 209-217, 2013.
78. A. M. Singh, M. Bechard, K. Smith, and S. Dalton, "Reconciling the different roles of Gsk3β in 'naïve' and 'primed' pluripotent stem cells, " Cell Cycle, vol. 11, no. 16, pp. 2991-2996, 2012.
79. F. D. Price, H. Yin, A. Jones, W. van Ijcken, F. Grosveld, and M. A. Rudnicki, "Canonical Wnt signaling induces a primitive endoderm metastable state in mouse embryonic stem cells, " Stem Cells, vol. 31, no. 4, pp. 752-764, 2013.
80. L. Marucci, E. Pedone, U. Di Vicino, B. Sanuy-Escribano, M. Isalan, and M. Cosma, "β-catenin fluctuates inmouse ESCs and is essential forNanog-mediated reprogramming of somatic cells to pluripotency, " Cell Reports, vol. 8, no. 6, pp. 1686-1696, 2014.
81. K. C. Davidson, A. M. Adams, J. M. Goodson et al., "Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 12, pp. 4485-4490, 2012.
82. T. A. Blauwkamp, S. Nigam, R. Ardehali, I. L. Weissman, and R. Nusse, "Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors, " Nature Communications, vol. 3, article 1070, 2012.
83. K. E. Galvin-Burgess, E. D. Travis, K. E. Pierson, and J. L. Vivian, "TGF-β-superfamily signaling regulates embryonic stem cell heterogeneity: self-renewal as a dynamic and regulated equilibrium, " Stem Cells, vol. 31, no. 1, pp. 48-58, 2013.
84. E. Mason, J. Mar, A. Laslett et al., "Gene expression variability as a unifying element of the pluripotency network, " Stem Cell Reports, vol. 3, no. 2, pp. 365-377, 2014.
85. A. B. Pardee, "A restriction point for control of normal animal cell proliferation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 4, pp. 1286-1290, 1974.
86. D. S. Dimitrova and D. M. Gilbert, "The spatial position and replication timing of chromosomal domains are both established in early G1 phase, " Molecular Cell, vol. 4, no. 6, pp. 983-993, 1999.
87. D. M. Gilbert, "Cell fate transitions and the replication timing decision point, "The Journal of Cell Biology, vol. 191, no. 5, pp. 899-903, 2010.
88. D. Grün, L. Kester, and A. van Oudenaarden, "Validation of noise models for single-cell transcriptomics, " Nature Methods, vol. 11, no. 6, pp. 637-640, 2014.
89. F. Buettner, K. N. Natarajan, F. P. Casale et al., "Computational analysis of cell-to-cell heterogeneity in single-cell RNAsequencing data reveals hidden subpopulations of cells, " Nature Biotechnology, vol. 33, no. 2, pp. 155-160, 2015.
90. S. A. Smallwood, H. J. Lee, C. Angermueller et al., "Singlecell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity, " Nature Methods, vol. 11, no. 8, pp. 817-820, 2014.
91. C. Lorthongpanich, L. F. Cheow, S. Balu et al., "Single-cell DNA-methylation analysis reveals epigenetic chimerism in preimplantation embryos, " Science, vol. 341, no. 6150, pp. 1110-1112, 2013.
92. T. Nagano, Y. Lubling, T. J. Stevens et al., "Single-cell Hi-C reveals cell-to-cell variability in chromosomestructure, " Nature, vol. 502, no. 7469, pp. 59-64, 2013.